Cover Image
市場調查報告書

Germinomatous(性原細胞瘤)生殖細胞瘤:全球臨床實驗檢討

Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 298503
出版日期 內容資訊 英文 60 Pages
訂單完成後即時交付
價格
Back to Top
Germinomatous(性原細胞瘤)生殖細胞瘤:全球臨床實驗檢討 Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014
出版日期: 2014年03月27日 內容資訊: 英文 60 Pages
簡介

本報告提供Germinomatous(性原細胞瘤)生殖細胞瘤的治療藥相關臨床實驗調查分析,提供臨床實驗數及被實驗人數,各階段及Phase別情況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:腫瘤科臨床實驗的Germinomatous(性原細胞瘤)生殖細胞瘤的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:腫瘤科臨床實驗的Germinomatous(性原細胞瘤)生殖細胞瘤的比例

各方面的臨床實驗

各階段臨床實驗

評估項目別臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有前途藥物

  • 主要大學·研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • European Organization for Research and Treatment of Cancer
    • Children's Oncology Group
    • The Royal Marsden NHS Foundation Trust
    • Barts and The London NHS Trust
    • Sheffield Teaching Hospitals NHS Foundation Trust
    • Indiana University School of Medicine
    • Abramson Cancer Center
    • Medical Research Council
    • Alberta Health Services

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2047CTIDB

GlobalData's clinical trial report, "Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014" provides data on the Germinomatous (Seminomatous) Germ Cell Tumors clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Germinomatous (Seminomatous) Germ Cell Tumors. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Germinomatous (Seminomatous) Germ Cell Tumors. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Germinomatous (Seminomatous) Germ Cell Tumors
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Germinomatous (Seminomatous) Germ Cell Tumors to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Germinomatous (Seminomatous) Germ Cell Tumors to Oncology Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Drugs
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • Children's Oncology Group
      • Clinical Trial Overview of Children's Oncology Group
      • The Royal Marsden NHS Foundation Trust
      • Clinical Trial Overview of The Royal Marsden NHS Foundation Trust
      • Barts and The London NHS Trust
      • Clinical Trial Overview of Barts and The London NHS Trust
      • Sheffield Teaching Hospitals NHS Foundation Trust
      • Clinical Trial Overview of Sheffield Teaching Hospitals NHS Foundation Trust
      • Indiana University School of Medicine
      • Clinical Trial Overview of Indiana University School of Medicine
      • Abramson Cancer Center
      • Clinical Trial Overview of Abramson Cancer Center
      • Medical Research Council
      • Clinical Trial Overview of Medical Research Council
      • Alberta Health Services
      • Clinical Trial Overview of Alberta Health Services
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials by Region, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Germinomatous (Seminomatous) Germ Cell Tumors to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Germinomatous (Seminomatous) Germ Cell Tumors to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by The Royal Marsden NHS Foundation Trust, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Barts and The London NHS Trust, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheffield Teaching Hospitals NHS Foundation Trust, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2014*

List of Figures

  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Germinomatous (Seminomatous) Germ Cell Tumors to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Germinomatous (Seminomatous) Germ Cell Tumors to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Germinomatous (Seminomatous) Germ Cell Tumors Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top